Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.

Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.

Item
http://www.wikidata.org/entity/Q35841848
GlycoMine(struct): a new bioinformatics tool for highly accurate mapping of the human N-linked and O-linked glycoproteomes by incorporating structural features.Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.Downregulation of BZW2 inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway.Silencing of ST6GalNAc I suppresses the proliferation, migration and invasion of hepatocarcinoma cells through PI3K/AKT/NF-κB pathway.MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway.Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage.Longitudinal Transcriptional Response of Glycosylation-Related Genes, Regulators, and Targets in Cancer Cell Lines Treated With 11 Antitumor Agents.Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?Progress and prospects of circular RNAs in Hepatocellular carcinoma: Novel insights into their function.ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway.Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1.Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer.Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery.CDCA8 expression and its clinical relevance in patients with bladder cancer
P2860

Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.

Item
http://www.wikidata.org/entity/Q35841848
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Abnormal Protein Glycosylation ...... sis and Targeted Therapeutics.
@ast
Abnormal Protein Glycosylation ...... sis and Targeted Therapeutics.
@en
type
label
Abnormal Protein Glycosylation ...... sis and Targeted Therapeutics.
@ast
Abnormal Protein Glycosylation ...... sis and Targeted Therapeutics.
@en
prefLabel
Abnormal Protein Glycosylation ...... sis and Targeted Therapeutics.
@ast
Abnormal Protein Glycosylation ...... sis and Targeted Therapeutics.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Abnormal Protein Glycosylation ...... osis and Targeted Therapeutics
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0141253
P407
P433
P478
P50
P577
P5875
P698
P921
P932